|
Table 7: Age-Adjusted Incidence Rates
(AAIR)* of Selected First Primary Malignant and Benign Central Nervous System
Tumors by Histology and Sex, 20-64 Year Olds, California, 2001-2005 |
||||||||||||||||||||||
|
Behavior |
Histology |
Sex |
|
Total |
|
NH White |
|
NH Black |
|
Hispanic |
|
API |
||||||||||
|
|
|
|
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|
AAIR |
95% CI |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malignant |
Astrocytoma,
anaplastic |
Total |
|
0.4 |
0.4 |
0.5 |
|
0.5 |
0.5 |
0.6 |
|
0.2 |
0.1 |
0.3 |
|
0.4 |
0.3 |
0.5 |
|
0.2 |
0.2 |
0.3 |
|
|
|
Male |
|
0.5 |
0.4 |
0.6 |
|
0.6 |
0.6 |
0.8 |
|
0.2 |
0.0 |
0.4 |
|
0.4 |
0.3 |
0.6 |
|
0.3 |
0.2 |
0.4 |
|
|
|
Female |
|
0.3 |
0.3 |
0.4 |
|
0.4 |
0.4 |
0.5 |
|
0.1 |
0.0 |
0.3 |
|
0.3 |
0.2 |
0.4 |
|
0.2 |
0.1 |
0.3 |
|
|
Astrocytoma,
NOS |
Total |
|
0.3 |
0.3 |
0.4 |
|
0.4 |
0.4 |
0.5 |
|
0.3 |
0.2 |
0.4 |
|
0.3 |
0.2 |
0.4 |
|
0.1 |
0.1 |
0.2 |
|
|
|
Male |
|
0.4 |
0.3 |
0.4 |
|
0.5 |
0.4 |
0.6 |
|
0.4 |
0.2 |
0.7 |
|
0.3 |
0.2 |
0.4 |
|
0.1 |
0.0 |
0.2 |
|
|
|
Female |
|
0.3 |
0.3 |
0.3 |
|
0.4 |
0.3 |
0.5 |
|
0.1 |
0.0 |
0.3 |
|
0.3 |
0.2 |
0.4 |
|
0.2 |
0.1 |
0.3 |
|
|
Glioblastoma |
Total |
|
2.2 |
2.1 |
2.3 |
|
2.8 |
2.7 |
3.0 |
|
1.3 |
1.1 |
1.7 |
|
1.8 |
1.6 |
2.0 |
|
1.0 |
0.9 |
1.2 |
|
|
|
Male |
|
2.9 |
2.7 |
3.0 |
|
3.6 |
3.4 |
3.9 |
|
1.8 |
1.4 |
2.4 |
|
2.0 |
1.8 |
2.3 |
|
1.4 |
1.1 |
1.7 |
|
|
|
Female |
|
1.6 |
1.5 |
1.7 |
|
2.0 |
1.8 |
2.2 |
|
0.9 |
0.6 |
1.3 |
|
1.5 |
1.3 |
1.7 |
|
0.7 |
0.5 |
0.9 |
|
|
Oligodendroglioma |
Total |
|
0.4 |
0.3 |
0.4 |
|
0.5 |
0.4 |
0.6 |
|
0.1 |
0.1 |
0.2 |
|
0.3 |
0.2 |
0.3 |
|
0.3 |
0.2 |
0.4 |
|
|
|
Male |
|
0.4 |
0.4 |
0.5 |
|
0.6 |
0.5 |
0.7 |
|
0.2 |
0.1 |
0.4 |
|
0.3 |
0.2 |
0.4 |
|
0.3 |
0.2 |
0.5 |
|
|
|
Female |
|
0.3 |
0.3 |
0.4 |
|
0.4 |
0.3 |
0.5 |
|
|
|
|
|
0.3 |
0.2 |
0.4 |
|
0.2 |
0.1 |
0.4 |
|
|
Anaplastic
oligodendroglioma |
Total |
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.2 |
0.3 |
|
|
|
|
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.1 |
0.2 |
|
|
|
Male |
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.2 |
0.3 |
|
|
|
|
|
0.1 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
|
|
Female |
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.2 |
0.3 |
|
|
|
|
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.0 |
0.2 |
|
|
Ependymomas,
anaplastic |
Total |
|
0.2 |
0.2 |
0.3 |
|
0.3 |
0.2 |
0.3 |
|
0.2 |
0.1 |
0.3 |
|
0.2 |
0.2 |
0.3 |
|
0.2 |
0.1 |
0.2 |
|
|
|
Male |
|
0.2 |
0.2 |
0.3 |
|
0.3 |
0.2 |
0.3 |
|
0.3 |
0.1 |
0.5 |
|
0.3 |
0.2 |
0.4 |
|
0.1 |
0.1 |
0.3 |
|
|
|
Female |
|
0.2 |
0.2 |
0.3 |
|
0.3 |
0.2 |
0.4 |
|
|
|
|
|
0.2 |
0.1 |
0.3 |
|
0.2 |
0.1 |
0.3 |
|
|
Mixed
glioma |
Total |
|
0.2 |
0.2 |
0.3 |
|
0.3 |
0.3 |
0.4 |
|
0.1 |
0.0 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
0.2 |
0.2 |
0.3 |
|
|
|
Male |
|
0.3 |
0.2 |
0.3 |
|
0.4 |
0.3 |
0.5 |
|
|
|
|
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.4 |
|
|
|
Female |
|
0.2 |
0.2 |
0.3 |
|
0.2 |
0.2 |
0.3 |
|
|
|
|
|
0.2 |
0.2 |
0.3 |
|
0.2 |
0.1 |
0.4 |
|
|
Glioma
malignant, NOS |
Total |
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.2 |
0.2 |
|
0.1 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.3 |
|
0.1 |
0.1 |
0.2 |
|
|
|
Male |
|
0.2 |
0.2 |
0.2 |
|
0.2 |
0.2 |
0.3 |
|
|
|
|
|
0.2 |
0.1 |
0.3 |
|
0.1 |
0.0 |
0.2 |
|
|
|
Female |
|
0.2 |
0.1 |
0.2 |
|
0.2 |
0.1 |
0.2 |
|
0.1 |
0.0 |
0.3 |
|
0.2 |
0.1 |
0.3 |
|
0.2 |
0.1 |
0.3 |
|
|
PNET/Meduloblastoma |
Total |
|
0.1 |
0.1 |
0.1 |
|
0.1 |
0.1 |
0.1 |
|
0.1 |
0.0 |
0.2 |
|
0.1 |
0.1 |
0.2 |
|
0.0 |
0.0 |
0.1 |
|
|
|
Male |
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.1 |
0.2 |
|
|
|
|
|
0.2 |
0.1 |
0.2 |
|
|
|
|
|
|
|
Female |
|
0.1 |
0.0 |
0.1 |
|
0.1 |
0.0 |
0.1 |
|
|
|
|
|
0.1 |
0.0 |
0.1 |
|
|
|
|
|
|
Lymphomas |
Total |
|
0.4 |
0.3 |
0.4 |
|
0.4 |
0.3 |
0.4 |
|
0.4 |
0.3 |
0.6 |
|
0.4 |
0.3 |
0.5 |
|
0.4 |
0.3 |
0.5 |
|
|
|
Male |
|
0.5 |
0.4 |
0.6 |
|
0.5 |
0.4 |
0.6 |
|
0.6 |
0.3 |
0.9 |
|
0.5 |
0.4 |
0.7 |
|
0.5 |
0.3 |
0.6 |
|
|
|
Female |
|
0.3 |
0.2 |
0.3 |
|
0.3 |
0.2 |
0.3 |
|
0.2 |
0.1 |
0.5 |
|
0.2 |
0.2 |
0.3 |
|
0.3 |
0.2 |
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benign |
Pilocytic
astrocytoma |
Total |
|
0.1 |
0.1 |
0.1 |
|
0.1 |
0.1 |
0.2 |
|
0.1 |
0.0 |
0.2 |
|
0.1 |
0.0 |
0.1 |
|
0.1 |
0.0 |
0.1 |
|
|
|
Male |
|
0.1 |
0.1 |
0.1 |
|
0.1 |
0.1 |
0.2 |
|
|
|
|
|
0.1 |
0.0 |
0.1 |
|
|
|
|
|
|
|
Female |
|
0.1 |
0.1 |
0.1 |
|
0.2 |
0.1 |
0.2 |
|
|
|
|
|
0.1 |
0.0 |
0.1 |
|
0.1 |
0.0 |
0.2 |
|
|
Nerve
sheath |
Total |
|
2.0 |
1.9 |
2.1 |
|
2.4 |
2.3 |
2.5 |
|
0.9 |
0.7 |
1.1 |
|
1.3 |
1.1 |
1.4 |
|
1.9 |
1.7 |
2.1 |
|
|
|
Male |
|
2.0 |
1.9 |
2.1 |
|
2.5 |
2.3 |
2.7 |
|
0.9 |
0.6 |
1.4 |
|
1.2 |
1.0 |
1.4 |
|
1.9 |
1.6 |
2.3 |
|
|
|
Female |
|
1.9 |
1.8 |
2.1 |
|
2.3 |
2.1 |
2.5 |
|
0.8 |
0.5 |
1.2 |
|
1.4 |
1.2 |
1.6 |
|
1.9 |
1.6 |
2.2 |
|
|
Meningioma |
Total |
|
3.8 |
3.7 |
3.9 |
|
4.1 |
3.9 |
4.2 |
|
4.1 |
3.6 |
4.6 |
|
3.2 |
3.0 |
3.5 |
|
3.3 |
3.0 |
3.7 |
|
|
|
Male |
|
1.9 |
1.8 |
2.1 |
|
2.2 |
2.1 |
2.4 |
|
2.0 |
1.6 |
2.6 |
|
1.3 |
1.1 |
1.5 |
|
1.7 |
1.4 |
2.0 |
|
|
|
Female |
|
5.6 |
5.4 |
5.8 |
|
5.9 |
5.6 |
6.2 |
|
6.0 |
5.2 |
6.9 |
|
5.2 |
4.8 |
5.6 |
|
4.8 |
4.3 |
5.3 |
|
|
Pituitary
tumors |
Total |
|
2.3 |
2.3 |
2.4 |
|
2.0 |
1.9 |
2.1 |
|
3.4 |
2.9 |
3.8 |
|
2.9 |
2.7 |
3.1 |
|
2.0 |
1.7 |
2.2 |
|
|
|
Male |
|
2.1 |
2.0 |
2.3 |
|
2.0 |
1.8 |
2.1 |
|
3.2 |
2.6 |
3.9 |
|
2.5 |
2.2 |
2.8 |
|
1.7 |
1.4 |
2.1 |
|
|
|
Female |
|
2.6 |
2.4 |
2.7 |
|
2.1 |
1.9 |
2.2 |
|
3.5 |
2.9 |
4.2 |
|
3.4 |
3.1 |
3.7 |
|
2.2 |
1.9 |
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
Age-adjusted incidence rates are per 100,000 population. Rates are standardized to the 2000 US
population. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||